Ruxolitinib Pre-, During- and Post-HSCT for Patients With Primary or Secondary Myelofibrosis.
Clinical trial NCT03427866 · COMPLETED
Trial details
- NCT number
- NCT03427866
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-28
- Primary completion
- 2024-05-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.